Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ilaria Emanuela Bossi
Observed names:
Bossi, Ilaria,
I. Bossi,
Ilaria Bossi
Institution:
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Observed institutions:
University of Milan,
Luigi Sacco Hospital,
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda,
Ospedale Sant'Anna,
St. Anna Hospital,
Fondazione IRCCS Istituto Nazionale dei Tumori
show all 6
ORCID:
0000-0003-2299-220X
Observed ORCID:
0000-0003-2299-220X
OpenAlex ID:
A5021598353
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis
2015
·
Filippo Pietrantonio
, Fausto Petrelli
, et al.
·
European Journal of Cancer
·
540
Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
2016
·
Filippo Pietrantonio
, Claudio Vernieri
, et al.
·
Clinical Cancer Research
·
196
PDF
Syncope clinical management in the emergency department: a consensus from the first international workshop on syncope risk stratification in the emergency department
2015
·
Giorgio Costantino
, Benjamin C. Sun
, et al.
·
European Heart Journal
·
148
PDF
Syncope Risk Stratification Tools vs Clinical Judgment: An Individual Patient Data Meta-analysis
2014
·
Giorgio Costantino
, Giovanni Casazza
, et al.
·
The American Journal of Medicine
·
136
Lung ultrasound and short-term prognosis in heart failure patients
2016
·
Chiara Cogliati
, Giovanni Casazza
, et al.
·
International Journal of Cardiology
·
95
Priorities for Emergency Department Syncope Research
2014
·
Benjamin C. Sun
, Giorgio Costantino
, et al.
·
Annals of Emergency Medicine
·
91
PDF
Lung ultrasound for monitoring cardiogenic pulmonary edema
2016
·
Francesca Cortellaro
, Elisa Ceriani
, et al.
·
Internal and Emergency Medicine
·
87
Toward the molecular dissection of peritoneal pseudomyxoma
2016
·
F. Pietrantonio
, F. Perrone
, et al.
·
Annals of Oncology
·
73
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan
2015
·
Felicia Stefania Falvella
, Stefania Cheli
, et al.
·
British Journal of Clinical Pharmacology
·
71
PDF
FOLFOX-4 Chemotherapy for Patients With Unresectable or Relapsed Peritoneal Pseudomyxoma
2014
·
Filippo Pietrantonio
, Claudia Maggi
, et al.
·
The Oncologist
·
67
A review on biomarkers for prediction of treatment outcome in gastric cancer.
2013
·
Filippo Pietrantonio
, Filippo De Braud
, et al.
·
PubMed
·
67
Role of cMET in the Development and Progression of Colorectal Cancer
2013
·
Juan Pérez-Vargas
, Pamela Biondani
, et al.
·
International Journal of Molecular Sciences
·
64
PDF
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study
2016
·
Filippo Pietrantonio
, Rosa Berenato
, et al.
·
Journal of Translational Medicine
·
48
PDF
Quality of life and everyday activities in patients with primary biliary cirrhosis
2007
·
Carlo Selmi
, Eric M. Gershwin
, et al.
·
Hepatology
·
47
PDF
Early goal-directed therapy vs usual care in the treatment of severe sepsis and septic shock: a systematic review and meta-analysis
2015
·
Anna Maria Rusconi
, Ilaria Bossi
, et al.
·
Internal and Emergency Medicine
·
38
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab
2015
·
Valeria Musella
, Filippo Pietrantonio
, et al.
·
International Journal of Cancer
·
37
PDF
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients
2017
·
Mariantonietta Di Salvatore
, Filippo Pietrantonio
, et al.
·
Oncotarget
·
34
PDF
Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens: Clinical outcome and biomarkers of efficacy
2013
·
Filippo Pietrantonio
, Federica Perrone
, et al.
·
Cancer Biology & Therapy
·
28
PDF
Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status
2014
·
Filippo Pietrantonio
, Claudia Maggi
, et al.
·
PLoS ONE
·
26
PDF
Eligibility criteria in heart failure randomized controlled trials: a gap between evidence and clinical practice
2008
·
Giorgio Costantino
, Anna Maria Rusconi
, et al.
·
Internal and Emergency Medicine
·
26
Long-term prophylaxis in hereditary angio-oedema: a systematic review
2012
·
Giorgio Costantino
, Giovanni Casazza
, et al.
·
BMJ Open
·
22
PDF
BRAF in Metastatic Colorectal Cancer: The Future Starts Now
2015
·
Armando Orlandi
, Maria Alessandra Calegari
, et al.
·
Pharmacogenomics
·
20
Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases
2016
·
Filippo Pietrantonio
, Maria Di Bartolomeo
, et al.
·
Clinical Colorectal Cancer
·
19
Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase
2015
·
Felicia Falvella
, Marta Caporale
, et al.
·
International Journal of Molecular Sciences
·
19
PDF
Factors Associated with ICU Admission following Blunt Chest Trauma
2016
·
Andrea Bellone
, Ilaria Bossi
, et al.
·
Canadian Respiratory Journal
·
15
PDF
Show more works
View as search
Works count:
71
Citation count:
2,079
H-index:
21
I10-index:
26
Year
Topic
Type